Who doesn’t want to minimize risks during pregnancy??

Scientists in Australia who reviewed over 30 trials found that taking aspirin during pregnancy may modestly reduce the risk of the mother developing pre- eclampsia, a condition characterized by high blood pressure that can lead to serious complications.

Pre-eclampsia affects the placenta, and sometimes the mother’s kidneys, liver and brain.

Mother’s blood pressure goes up and her urine contains high concentrations of protein (because of kidney problems). It can also give her abdominal pain, headache and swelling.

The various researches and results showed that the women who received antiplatelet agents were 10 per cent less likely to develop pre-eclampsia, of delivering before 34 weeks, and of having a serious outcome from the pregnancy compared to women in the control group. Antiplatelet agents did not affect the risk of death of the fetus or baby, the size of the baby, or bleeding events in either the mothers or their babies.

So why not consider reductions in the relative risk of pre-eclampsia, of birth before 34 weeks’ gestation, and of having a pregnancy without possibility of a serious adverse outcome.